There's lots of excitement about the new protease inhibitors

There's lots of excitement about the new protease inhibitors...because of their dramatic effects on suppressing the HIV virus.

The FDA approved the first protease inhibitor, saquinavir (Invirase), in December.

Now there's ritonavir (Norvir) and indinavir (Crixivan). These latest two drugs seem to be more active against HIV than the first one.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote